Table of Contents Peripheral Arterial Disease (PAD) Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Peripheral Arterial Disease (PAD) Therapeutics 1.1 Peripheral Arterial Disease (PAD) Therapeutics Market Overview 1.1.1 Peripheral Arterial Disease (PAD) Therapeutics Product Scope 1.1.2 Market Status and Outlook 1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Peripheral Arterial Disease (PAD) Therapeutics Market by Type 1.3.1 Anti-Platelet Drugs 1.3.2 Dual Antiplatelet Therapy Drugs 1.3.3 Others 1.4 Peripheral Arterial Disease (PAD) Therapeutics Market by End Users/Application 1.4.1 Hospitals 1.4.2 Clinics 1.4.3 Others 2 Global Peripheral Arterial Disease (PAD) Therapeutics Competition Analysis by Players 2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 AstraZeneca Plc. (UK) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Bayer HealthCare Pharmaceuticals (Germany) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 Bristol-Myers Squibb Company (US) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 Merck & Co., Inc. (US) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Proteon Therapeutics, Inc. (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Sanofi S.A. (France) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Symic Bio, Inc. (US) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 TheraVasc Inc. (US) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 AnGes MG, Inc. (Japan) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.9.5 Recent Developments 3.10 Athersys, Inc. (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) (2014-2019) 3.10.5 Recent Developments 3.11 Betagenon AB (Sweden) 3.12 miRagen Therapeutics, Inc. (US) 3.13 Multi Gene Vascular Systems Ltd (Israel) 3.14 ViroMed Co. Ltd. (Korea) 4 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type and Application (2014-2019) 4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2014-2019) 4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2014-2019) 4.3 Potential Application of Peripheral Arterial Disease (PAD) Therapeutics in Future 4.4 Top Consumer/End Users of Peripheral Arterial Disease (PAD) Therapeutics 5 North America Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 5.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 5.2 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 6 Europe Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 6.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 6.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 7 China Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 7.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 7.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 8.1 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 8.2 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 9.1 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 9.2 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Development Status and Outlook 10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (2014-2019) 10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Regions (2019-2025) 11.1.1 North America Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.3 China Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate (2019-2025) 11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) by Type (2019-2025) 11.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2019-2025) 12 Peripheral Arterial Disease (PAD) Therapeutics Market Dynamics 12.1 Peripheral Arterial Disease (PAD) Therapeutics Market Opportunities 12.2 Peripheral Arterial Disease (PAD) Therapeutics Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Peripheral Arterial Disease (PAD) Therapeutics Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Peripheral Arterial Disease (PAD) Therapeutics Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Peripheral Arterial Disease (PAD) Therapeutics Product Scope Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) (2014-2019) Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions in 2018 Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type in 2018 Figure Anti-Platelet Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Dual Antiplatelet Therapy Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Others Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2018 Table Key Downstream Customer in Hospitals Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2014-2019) Table Key Downstream Customer in Clinics Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2014-2019) Table Key Downstream Customer in Others Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate in Others (2014-2019) Table Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2018 and 2019) Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Table AstraZeneca Plc. (UK) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of AstraZeneca Plc. (UK) (2014-2019) Figure AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Bayer HealthCare Pharmaceuticals (Germany) (2014-2019) Figure Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Bristol-Myers Squibb Company (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Bristol-Myers Squibb Company (US) (2014-2019) Figure Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Merck & Co., Inc. (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Merck & Co., Inc. (US) (2014-2019) Figure Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Proteon Therapeutics, Inc. (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Proteon Therapeutics, Inc. (US) (2014-2019) Figure Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Sanofi S.A. (France) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Sanofi S.A. (France) (2014-2019) Figure Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Symic Bio, Inc. (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Symic Bio, Inc. (US) (2014-2019) Figure Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table TheraVasc Inc. (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of TheraVasc Inc. (US) (2014-2019) Figure TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table AnGes MG, Inc. (Japan) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of AnGes MG, Inc. (Japan) (2014-2019) Figure AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 20187 Table Athersys, Inc. (US) Basic Information List Table Peripheral Arterial Disease (PAD) Therapeutics Business Revenue (Million USD) of Athersys, Inc. (US) (2014-2019) Figure Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Business Revenue Market Share in 2018 Table Betagenon AB (Sweden) Basic Information List Table miRagen Therapeutics, Inc. (US) Basic Information List Table Multi Gene Vascular Systems Ltd (Israel) Basic Information List Table ViroMed Co. Ltd. (Korea) Basic Information List Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Type (2014-2019) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2014 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2015 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2016 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2017 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2018 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2019 Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application (2014-2019) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2014 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2015 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2017 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2018 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Peripheral Arterial Disease (PAD) Therapeutics Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure China Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2018 Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Players in 2019 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Regions (2019-2025) Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Regions (2019-2025) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions in 2019 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Regions in 2025 Figure North America Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure China Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue (Million USD) and Growth Rate (2019-2025) Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Type (2019-2025) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2019 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type in 2025 Table Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application (2019-2025) Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2019 Figure Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Million USD) by Application in 2025

AstraZeneca Plc. (UK) Bayer HealthCare Pharmaceuticals (Germany) Bristol-Myers Squibb Company (US) Merck & Co., Inc. (US) Proteon Therapeutics, Inc. (US) Sanofi S.A. (France) Symic Bio, Inc. (US) TheraVasc Inc. (US) AnGes MG, Inc. (Japan) Athersys, Inc. (US) Betagenon AB (Sweden) miRagen Therapeutics, Inc. (US) Multi Gene Vascular Systems Ltd (Israel) ViroMed Co. Ltd. (Korea)